Skip to main content

Ceragon Networks Ltd. (CRNT) Stock Forecast

Data as of Aug 8, 2026

Technology · Current price $2.20 (-0.90%)

Consensus Target
$4.25
Upside
+93.2%
Analysts
1
Rating
Buy(2.00)

Price Target Range

Low $4.00Consensus $4.25High $4.50
▲ Current $2.20

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

CRNT vs Sector & Market

MetricCRNTTechnology AvgLarge Cap Avg
Analyst Rating2.002.362.42
Analyst Count11418
Target Upside+93.2%+1680.2%+14.7%
P/E Ratio-107.0940.7536.06

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$94M$96M$98M2
2026-12-31$97M$99M$101M3
2027-03-31$89M$91M$93M3
2027-06-30$93M$95M$97M2
2027-09-30$98M$100M$102M2
2027-12-31$101M$103M$105M3
2028-12-31$386M$388M$392M2

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$0.05$0.06$0.061
2026-12-31$0.07$0.07$0.071
2027-03-31$0.04$0.04$0.041
2027-06-30$0.05$0.06$0.061
2027-09-30$0.07$0.07$0.071
2027-12-31$0.08$0.08$0.081
2028-12-31$0.25$0.25$0.251

Frequently Asked Questions

What is the analyst consensus for CRNT?

The consensus among 1 analysts covering Ceragon Networks Ltd. (CRNT) is Buy with an average price target of $4.25.

What is the highest price target for CRNT?

The highest analyst price target for CRNT is $4.50.

What is the lowest price target for CRNT?

The lowest analyst price target for CRNT is $4.00.

How many analysts cover CRNT?

1 analysts have issued ratings for Ceragon Networks Ltd. in the past 12 months.

Is CRNT a buy or sell right now?

Based on 1 analyst ratings, CRNT has a consensus rating of Buy (2.00/5) with a +93.2% upside to the consensus target of $4.25.

What are the earnings estimates for CRNT?

Analysts estimate CRNT will report EPS of $0.06 for the period ending 2026-09-30, with revenue estimated at $96M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.